These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34460979)

  • 21. Identification of a novel mutation in congenital afibrinogenemia in Iranian patients.
    Nojehdeh ST; Mojbafan M; Masoodifard M; Amini M; Zeinali S
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):323-327. PubMed ID: 33901106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical phenotypes and genotypes of congenital fibrinogen disorder: an analysis of 16 children].
    Wang M; Chen TP; Jiang AS; Zhao YH; Zhu CL; Wei N; Jin YT; Qu LJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):840-844. PubMed ID: 39148389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.
    Vu D; Bolton-Maggs PH; Parr JR; Morris MA; de Moerloose P; Neerman-Arbez M
    Blood; 2003 Dec; 102(13):4413-5. PubMed ID: 12893758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.
    Monaldini L; Asselta R; Duga S; Peyvandi F; Karimi M; Malcovati M; Tenchini ML
    Thromb Haemost; 2007 Apr; 97(4):546-51. PubMed ID: 17393016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fibrinogen B beta chain frameshift mutation causes congenital afibrinogenaemia.
    Zhang J; Zhao X; Wang Z; Yu Z; Cao L; Zhang W; Bai X; Ruan C
    Thromb Haemost; 2013 Jul; 110(1):76-82. PubMed ID: 23740095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
    Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
    Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.
    Levrat E; Aboukhamis I; de Moerloose P; Farho J; Chamaa S; Reber G; Fort A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):148-50. PubMed ID: 21245743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Frameshift Mutation in the FGA Gene (c.196 delT) Leading to Congenital Afibrinogenemia.
    Aydin Köker S; Köker A; Neerman-Arbez M; Ö Tunçer G; Akbas Y; Kara TT; Coban Y
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e98-e99. PubMed ID: 31725541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream.
    Robert-Ebadi H; de Moerloose P; El Khorassani M; El Khattab M; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):385-7. PubMed ID: 19417632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
    Mohsenian S; Palla R; Menegatti M; Cairo A; Lecchi A; Casini A; Neerman-Arbez M; Asselta R; Scardo S; Siboni SM; Blatny J; Zapletal O; Schved JF; Giansily-Blaizot M; Halimeh S; Daoud MA; Platokouki H; Pergantou H; Schutgens REG; Van Haaften-Spoor M; Brons P; Laros-van Gorkom B; Van Pinxten E; Borhany M; Fatima N; Mikovic D; Saracevic M; Özdemir GN; Ay Y; Makris M; Lockley C; Mumford A; Harvey A; Austin S; Shapiro A; Williamson A; McGuinn C; Goldberg I; De Moerloose P; Peyvandi F
    Blood Adv; 2024 Mar; 8(6):1392-1404. PubMed ID: 38286442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and Functional Characterization of Four Novel Fibrinogen Mutations in
    Ceznerová E; Kaufmanová J; Sovová Ž; Štikarová J; Loužil J; Kotlín R; Suttnar J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of a pedigree affected with congenital dysfibrinogenemia due to a novel Gly31Glu mutation of FGA gene].
    Wang X; Yang X; Yang W; Shu K; Li F; Liu J; Zhang Z; Li S; Jiang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep; 36(9):901-904. PubMed ID: 31515786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis of quantitative fibrinogen disorders.
    Asselta R; Duga S; Tenchini ML
    J Thromb Haemost; 2006 Oct; 4(10):2115-29. PubMed ID: 16999847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.
    Casini A; Lukowski S; Quintard VL; Crutu A; Zak M; Regazzoni S; de Moerloose P; Neerman-Arbez M
    Thromb Res; 2014 May; 133(5):868-74. PubMed ID: 24560896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.
    Ivaškevičius V; Rühl H; Detarsio G; Biswas A; Gupta S; Davoli M; Quartara A; Pérez S; Raviola M; Oldenburg J
    Hamostaseologie; 2016 Nov; 36(Suppl. 2):S34-S38. PubMed ID: 27824214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in exon 2 of FGB caused by c.221G>T
    Shlebak AA; Katsarou AD; Adams G; Fernando F
    J Thromb Thrombolysis; 2017 Feb; 43(2):263-270. PubMed ID: 27812779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.